We demonstrate that albumin infusions to increase serum albumin >30 g/L in hospitalized patients with decompensated cirrhosis had no immunomodulatory or anti-inflammatory effect, nor improved circulating albumin function over standard care, in which little albumin was administered. The gene discussed is ALB; the disease is Cirrhosis.